OTCBX
Price
$21.73
Change
-$0.72 (-3.21%)
Updated
Feb 21 closing price
Net Assets
15.5B
PMBPX
Price
$44.27
Change
-$0.76 (-1.69%)
Updated
Feb 21 closing price
Net Assets
30.08B
Ad is loading...

OTCBX vs PMBPX

Header iconOTCBX vs PMBPX Comparison
Open Charts OTCBX vs PMBPXBanner chart's image
MFS Mid Cap Growth B
Price$21.73
Change-$0.72 (-3.21%)
VolumeN/A
Net Assets15.5B
Principal MidCap R5
Price$44.27
Change-$0.76 (-1.69%)
VolumeN/A
Net Assets30.08B
OTCBX vs PMBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OTCBX vs. PMBPX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTCBX is a StrongBuy and PMBPX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 30.1B vs. OTCBX (15.5B). OTCBX (0.00) and PMBPX (0.00) have matching dividends . OTCBX was incepted earlier than PMBPX: OTCBX (31 years) vs PMBPX (24 years). OTCBX is a more actively managed with annual turnover of: 30.00 vs. PMBPX (10.10). PMBPX has a lower initial minimum investment than OTCBX: PMBPX (0) vs OTCBX (1000). PMBPX annual gain was more profitable for investors over the last year : 17.07 vs. OTCBX (4.40). PMBPX return over 5 years is better than : 38.64 vs. OTCBX (25.30).
OTCBXPMBPXOTCBX / PMBPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years24 years-
Gain YTD5.8064.533128%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets15.5B30.1B51%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.4017.0726%
Returns for 3 years13.5629.5146%
Returns for 5 years25.3038.6465%
Returns for 10 years79.7997.5182%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BALY17.330.44
+2.61%
Bally's Corporation
BIO285.631.90
+0.67%
Bio-Rad Laboratories IncClass A
GPUS3.150.02
+0.64%
Hyperscale Data Inc
PTGX38.49-0.04
-0.10%
Protagonist Therapeutics
MIST2.06-0.07
-3.29%
Milestone Pharmaceuticals